0001671858-16-000001.txt : 20160412 0001671858-16-000001.hdr.sgml : 20160412 20160412125206 ACCESSION NUMBER: 0001671858-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160412 DATE AS OF CHANGE: 20160412 EFFECTIVENESS DATE: 20160412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silverback Therapeutics, Inc. CENTRAL INDEX KEY: 0001671858 IRS NUMBER: 811489190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261099 FILM NUMBER: 161566754 BUSINESS ADDRESS: STREET 1: 14075 NE 30TH PLACE CITY: BELLEVUE STATE: WA ZIP: 98007 BUSINESS PHONE: 212-739-6451 MAIL ADDRESS: STREET 1: 14075 NE 30TH PLACE CITY: BELLEVUE STATE: WA ZIP: 98007 D 1 primary_doc.xml X0707 D LIVE 0001671858 Silverback Therapeutics, Inc. 14075 NE 30TH PLACE BELLEVUE WA WASHINGTON 98007 212-739-6451 DELAWARE None None Corporation true 2016 Peter A. Thompson 14075 NE 30th Place Bellevue WA WASHINGTON 98007 Executive Officer Director Biotechnology Decline to Disclose 06b false 2016-03-31 false true false 0 200 200 0 false 2 0 0 0 false Silverback Therapeutics, Inc. Peter A. Thompson Peter A. Thompson President & CEO 2016-04-07